CURO Group Holdings (CURO) IPO Opens Up 11%

Today's IPO for CURO Group Holdings Corp. (NYSE: CURO) opened for trading at $14.80 after pricing its initial public offering of 6,666,667 shares of common stock at a price to the public of $14.00 per share.

The underwriters have a 30-day option to purchase up to an additional 1,000,000 shares at the initial public offering price, less the underwriting discount to cover over-allotments, if any.

CURO will use the net proceeds from this offering to purchase, repurchase, redeem, defease or otherwise repay portions of the 12.00% Senior Secured Notes due 2022 of CURO’s wholly-owned subsidiary and to pay related fees, expenses, premiums and accrued interest.

Credit Suisse Securities (USA) LLC, Jefferies LLC and Stephens Inc. are acting as joint book-running managers and as representatives of the underwriters for the offering. William Blair & Company, L.L.C. is also acting as a bookrunning manager for the offering.

CURO, operating in three countries and powered by its fully integrated technology platform, is a market leader by revenues in providing short-term credit to underbanked consumers. In 1997, the Company was founded in Riverside, California by three Wichita, Kansas childhood friends to meet the growing consumer need for short-term loans. Their success led to opening stores across the United States, and expanding to offer online loans and financial services across three countries. Today, CURO combines its market expertise with a fully integrated technology platform, omni-channel approach and advanced credit decisioning to provide an array of short-term credit products across all mediums. CURO operates under a number of brands including Speedy Cash, Rapid Cash, Cash Money, LendDirect, Avio Credit, WageDayAdvance, Juo Loans, and Opt+. With over 20 years of operating experience, CURO provides financial freedom to the underbanked.

You May Also Be Interested In

• Entrata (ENT) files for proposed IPO
• Deutsche Bank Starts SPIE SA (SPIE:FP) (SPIWF) at Buy
• Jefferies Starts Latigo Biotherapeutics (LTGO) at Buy